Production (Stage)
CureVac N.V.
CVAC
$5.54
-$0.035-0.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 166.71% | 162.53% | 74.92% | 4.30% | 2.04% |
| Total Depreciation and Amortization | -19.24% | -20.61% | 18.54% | 28.11% | -1.51% |
| Total Amortization of Deferred Charges | 9.76% | 9.76% | -22.22% | -50.06% | -50.06% |
| Total Other Non-Cash Items | -10.01% | 35.37% | 21.53% | -34.29% | 6.99% |
| Change in Net Operating Assets | -21.94% | -75.05% | -70.13% | -50.12% | -56.66% |
| Cash from Operations | 159.77% | 138.19% | 69.38% | -19.28% | -9.72% |
| Capital Expenditure | 78.19% | 72.62% | 55.97% | 51.28% | 45.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.55% | -42.03% | -81.45% | -76.53% | 39.64% |
| Cash from Investing | 70.75% | 66.61% | 50.72% | 44.70% | 44.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.07% | 1.52% | 1.46% | -7.12% | -12.46% |
| Issuance of Common Stock | -89.09% | -99.94% | -99.95% | -99.88% | -99.87% |
| Repurchase of Common Stock | 24.18% | 24.18% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 250.00% | -- | -100.00% |
| Cash from Financing | -6.27% | -102.23% | -101.97% | -101.72% | -101.69% |
| Foreign Exchange rate Adjustments | 175.84% | 188.88% | 78.81% | 95.61% | -107.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -200.00% | -- | -- |
| Net Change in Cash | 144.00% | 183.81% | -56.54% | -933.79% | -792.07% |